Carmel, IN, United States of America

Guomin Shan

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 957(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Guomin Shan: Innovator in Monoclonal Antibodies

Introduction

Guomin Shan is a prominent inventor based in Carmel, IN (US), known for his significant contributions to the field of biotechnology. He holds a total of 4 patents, showcasing his expertise and innovative spirit in developing monoclonal antibodies and detection methods.

Latest Patents

One of his latest patents involves monoclonal antibodies specific for Cry1Ca and related detection methods. This patent describes murine monoclonal antibodies and methods that are useful for determining and quantifying the presence of Cry1Ca delta endotoxin. The claimed antibodies specifically bind the core toxin region, making them suitable for detecting the native full-length Cry1Ca toxin as well as the amino core toxin and N-terminal 29 residue truncated forms. Another notable patent focuses on monoclonal antibodies and detection methods for the phosphinothricin-N-acetyl-transferase enzyme. This invention provides methods for determining and quantifying the presence of this enzyme, which is particularly useful for identifying and quantifying phosphinothricin-N-acetyl-transferase expressed in transgenic plants.

Career Highlights

Guomin Shan is currently employed at Dow Agrosciences LLC, where he continues to push the boundaries of innovation in agricultural biotechnology. His work has had a significant impact on the development of new methods for detecting important agricultural toxins and enzymes.

Collaborations

Throughout his career, Guomin has collaborated with notable colleagues, including Eric Hongzheng Ma and Gaofeng Lin. These collaborations have further enhanced his research and development efforts in the field.

Conclusion

Guomin Shan's contributions to the field of biotechnology, particularly in the development of monoclonal antibodies, highlight his role as an influential inventor. His innovative patents and ongoing work at Dow Agrosciences LLC continue to advance the understanding and application of biotechnology in agriculture.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…